Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients.

[1]  N. Pritchard,et al.  Corneal and Retinal Neuronal Degeneration in Early Stages of Diabetic Retinopathy. , 2017, Investigative ophthalmology & visual science.

[2]  Dong Hoon Lee,et al.  Metformin protects against retinal cell death in diabetic mice. , 2017, Biochemical and biophysical research communications.

[3]  Gary C Lee,et al.  Ganglion Cell-Inner Plexiform Layer Change Detected by Optical Coherence Tomography Indicates Progression in Advanced Glaucoma. , 2017, Ophthalmology.

[4]  E. Goldberg,et al.  Relationship Between Serum Glucose Levels and Intraocular Pressure, a Population-based Cross-sectional Study , 2017, Journal of glaucoma.

[5]  C. O'brien,et al.  Mitochondrial dysfunction in ocular disease: Focus on glaucoma. , 2017, Mitochondrion.

[6]  F. Medeiros,et al.  Comparing the Rates of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Loss in Healthy Eyes and in Glaucoma Eyes. , 2017, American journal of ophthalmology.

[7]  A. Bashier,et al.  Effect of Metformin on Different Non-Diabetes Related Conditions, a Special Focus on Malignant Conditions: Review of Literature , 2017, Journal of clinical medicine research.

[8]  J. Manson,et al.  Management of Type 2 Diabetes in 2017: Getting to Goal. , 2017, JAMA.

[9]  H. Krumholz,et al.  Is Hemoglobin A1c the Right Outcome for Studies of Diabetes? , 2017, JAMA.

[10]  Robert N Weinreb,et al.  Optical Coherence Tomography Angiography Vessel Density in Glaucomatous Eyes with Focal Lamina Cribrosa Defects. , 2016, Ophthalmology.

[11]  L. Aiello,et al.  Presence and Risk Factors for Glaucoma in Patients with Diabetes , 2016, Current Diabetes Reports.

[12]  S. Mansberger,et al.  Effect of Restricting Perimetry Testing Algorithms to Reliable Sensitivities on Test-Retest Variability , 2016, Investigative ophthalmology & visual science.

[13]  Alberto Diniz-Filho,et al.  The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma , 2016, Investigative ophthalmology & visual science.

[14]  U. Frydkjaer-Olsen,et al.  Vascular Changes and Neurodegeneration in the Early Stages of Diabetic Retinopathy: Which Comes First? , 2016, Ophthalmic Research.

[15]  G. Pugliese,et al.  Abnormalities of retinal ganglion cell complex at optical coherence tomography in patients with type 2 diabetes: a sign of diabetic polyneuropathy, not retinopathy. , 2016, Journal of diabetes and its complications.

[16]  R. Simó,et al.  Neuroprotection as a Therapeutic Target for Diabetic Retinopathy , 2016, Journal of diabetes research.

[17]  Ertuğrul Can,et al.  Comparison of the corneal biomechanical properties, optic nerve head topographic parameters, and retinal nerve fiber layer thickness measurements in diabetic and non-diabetic primary open-angle glaucoma , 2016, International Ophthalmology.

[18]  Ertuğrul Can,et al.  Comparison of Optic Nerve Head Topographic Parameters in Patients With Primary Open-Angle Glaucoma With and Without Diabetes Mellitus , 2016, Journal of glaucoma.

[19]  J. Cunha,et al.  Diabetes Mellitus as a Risk Factor in Glaucoma’s Physiopathology and Surgical Survival Time: A Literature Review , 2015, Journal of current glaucoma practice.

[20]  B. Nan,et al.  Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus. , 2015, JAMA ophthalmology.

[21]  F. Medeiros,et al.  The pathophysiology and treatment of glaucoma: a review. , 2014, JAMA.

[22]  Robert N Weinreb,et al.  Rates of retinal nerve fiber layer thinning in glaucoma suspect eyes. , 2013, Ophthalmology.

[23]  P. Khaw,et al.  VEGF-A Is Necessary and Sufficient for Retinal Neuroprotection in Models of Experimental Glaucoma , 2013, The American journal of pathology.

[24]  A. Vingrys,et al.  Clinical and experimental links between diabetes and glaucoma , 2011, Clinical & experimental optometry.

[25]  Milan Sonka,et al.  Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. , 2010, Investigative ophthalmology & visual science.

[26]  Robert N Weinreb,et al.  The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data. , 2009, Archives of ophthalmology.

[27]  F. Medeiros,et al.  The Relationship between intraocular pressure and progressive retinal nerve fiber layer loss in glaucoma. , 2009, Ophthalmology.

[28]  S. Miglior,et al.  Risk factors for glaucoma onset and progression. , 2008, Survey of ophthalmology.

[29]  S. Azen,et al.  Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study. , 2008, Ophthalmology.

[30]  J. Beiser,et al.  Is a history of diabetes mellitus protective against developing primary open-angle glaucoma? , 2008, Archives of ophthalmology.

[31]  M. Sugimoto,et al.  Detection of Early Diabetic Change with Optical Coherence Tomography in Type 2 Diabetes Mellitus Patients without Retinopathy , 2005, Ophthalmologica.

[32]  P. Khaw,et al.  Primary open-angle glaucoma , 2004, The Lancet.

[33]  A. Investigators.  The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. , 2002, American journal of ophthalmology.

[34]  Chris A. Johnson,et al.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. , 2002, Archives of ophthalmology.

[35]  R. P. Mills,et al.  Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. , 2001, Ophthalmology.

[36]  S. Drance,et al.  Risk factors for progression of visual field abnormalities in normal-tension glaucoma. , 2001, American journal of ophthalmology.

[37]  A Heijl,et al.  Early Manifest Glaucoma Trial: design and baseline data. , 1999, Ophthalmology.

[38]  Douglas R. Anderson,et al.  Clinical Decisions In Glaucoma , 1993 .

[39]  Ching-Yu Cheng,et al.  Associations between chronic systemic diseases and primary open angle glaucoma: an epidemiological perspective , 2017, Clinical & experimental ophthalmology.

[40]  M. Faiq,et al.  Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent. , 2017, Current molecular medicine.

[41]  G. Querques,et al.  Optical Coherence Tomography Angiography of Diabetic Retinopathy. , 2016, Developments in ophthalmology.